Bosnia and Herzegovina vs Switzerland: The number of people with susceptibility test result for rifampicin

Bosnia and Herzegovina
255
in 2021
Switzerland
220
in 2021
Bosnia and Herzegovina rank
89th
Switzerland rank
92nd

The number of people with susceptibility test result for rifampicin over time

  • Bosnia and Herzegovina
  • Switzerland
0100200300400201720192021

How they compare

Bosnia and Herzegovina currently reports 255 against 220 in Switzerland, a difference of 35.

That makes Bosnia and Herzegovina's figure about 1.2 times Switzerland's.

Across all 5 years both countries report, Bosnia and Herzegovina has been ahead every year.

Bosnia and Herzegovina ranks 89th and Switzerland ranks 92nd of 155 countries.

Bosnia and Herzegovina has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Bosnia and Herzegovina Switzerland Difference Ahead
2010s 362 240.33 121.67 Bosnia and Herzegovina
2020s 231.5 195.5 36 Bosnia and Herzegovina

Averages of every year both report within each decade.

Frequently asked questions

Which has higher the number of people with susceptibility test result for rifampicin, Bosnia and Herzegovina or Switzerland?
Bosnia and Herzegovina, at 255 against 220 in Switzerland as of 2021.
What is the difference in the number of people with susceptibility test result for rifampicin between Bosnia and Herzegovina and Switzerland?
35, with Bosnia and Herzegovina ahead.
How many years of comparable data are there for Bosnia and Herzegovina and Switzerland?
5 years are reported by both, from 2017 to 2021.
How do Bosnia and Herzegovina and Switzerland rank globally for the number of people with susceptibility test result for rifampicin?
Bosnia and Herzegovina ranks 89th and Switzerland ranks 92nd of 155 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Bosnia and Herzegovina vs Switzerland: The number of people with susceptibility test result for rifampicin. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 18 September 2026, from https://health.statizoid.com/compare/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/bosnia-and-herzegovina/switzerland/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/bosnia-and-herzegovina/switzerland/">Bosnia and Herzegovina vs Switzerland: The number of people with susceptibility test result for rifampicin</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed